SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Bharat Parenterals - Quaterly Results

09 Aug 2023 Evaluate
The total revenue stands at Rs. 699.10 millions for the June 2023 quarter. The mentioned figure indicates an increase of about 167.96% as against Rs. 260.90 millions during  the year-ago period.Net Profit for the quarter ended June 2023 zoomed to 611.20% from Rs. 12.50 millions to Rs. 88.90  millions.Operating profit for the quarter ended June 2023 rose to 143.50 millions as compared to 34.70 millions of corresponding quarter ended June 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 699.10 260.90 167.96 699.10 260.90 167.96 2179.80 2120.10 2.82
Other Income 28.60 15.40 85.71 28.60 15.40 85.71 188.40 77.80 142.16
PBIDT 143.50 34.70 313.54 143.50 34.70 313.54 402.10 360.00 11.69
Interest 8.80 2.50 252.00 8.80 2.50 252.00 21.90 9.70 125.77
PBDT 134.70 32.20 318.32 134.70 32.20 318.32 380.20 350.30 8.54
Depreciation 15.10 15.40 -1.95 15.10 15.40 -1.95 58.50 66.60 -12.16
PBT 119.60 16.80 611.90 119.60 16.80 611.90 321.70 283.70 13.39
TAX 30.70 4.30 613.95 30.70 4.30 613.95 78.30 70.70 10.75
Deferred Tax -1.40 -0.60 133.33 -1.40 -0.60 133.33 -5.70 -9.40 -39.36
PAT 88.90 12.50 611.20 88.90 12.50 611.20 243.40 213.00 14.27
Equity 57.70 57.70 0.00 57.70 57.70 0.00 57.70 57.70 0.00
PBIDTM(%) 20.53 13.30 54.33 20.53 13.30 54.33 18.45 16.98 8.64

Bharat Parenterals Share Price

1199.80 -13.30 (-1.10%)
20-Apr-2026 14:28 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1670.85
Dr. Reddys Lab 1236.40
Cipla 1233.10
Zydus Lifesciences 937.40
Lupin 2329.40
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×